Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.45
+0.21 (1.91%)
At close: Oct 8, 2025, 4:00 PM EDT
11.48
+0.04 (0.31%)
After-hours: Oct 8, 2025, 5:08 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $156.00 million as of October 8, 2025. Its market cap has decreased by -20.24% in one year.
Market Cap
156.00M
Enterprise Value
152.87M
1-Year Change
-20.24%
Ranking
Category
Stock Price
$11.45
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $156.00M, an increase of 127.11%. That is a compound annual growth rate of 17.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 153.07M | 3.69% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.15B |
| Johnson & Johnson | 451.65B |
| AbbVie | 411.03B |
| UnitedHealth Group | 328.71B |
| AstraZeneca | 265.89B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |